enVVeno Medical Corp
General ticker "NVNO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $47.8M
enVVeno Medical Corp does not follow the US Stock Market performance with the rate: -16.5%.
Estimated limits based on current volatility of 5.2%: low 2.53$, high 2.81$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.01$, 7.03$]
- 2024-12-30 to 2025-12-30 estimated range: [2.85$, 6.73$]
Financial Metrics affecting the NVNO estimates:
- Negative: Non-GAAP EPS, $ of -1.92 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -27.65 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: -0.96 < Investing cash flow per share, $ of -0.64
Short-term NVNO quotes
Long-term NVNO plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $16.89MM | $24.93MM | $25.24MM |
Operating Income | $-16.89MM | $-24.93MM | $-25.24MM |
Non-Operating Income | $0.36MM | $0.26MM | $1.72MM |
R&D Expense | $5.73MM | $9.91MM | $13.58MM |
Income(Loss) | $-16.53MM | $-24.67MM | $-23.52MM |
Profit(Loss) | $-16.53MM | $-24.67MM | $-23.52MM |
Stockholders Equity | $54.40MM | $38.73MM | $46.20MM |
Assets | $57.70MM | $41.66MM | $48.63MM |
Operating Cash Flow | $-11.85MM | $-15.62MM | $-18.86MM |
Capital expenditure | $0.37MM | $0.12MM | $0.03MM |
Investing Cash Flow | $-0.37MM | $-34.55MM | $-7.87MM |
Financing Cash Flow | $57.61MM | $0.00MM | $25.79MM |
Earnings Per Share* | $-1.87 | $-2.16 | $-1.91 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.